VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $15,475 | -26.3% | 2,094 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $21,000 | -8.7% | 2,094 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $23,000 | -23.3% | 2,094 | -21.2% | 0.00% | 0.0% |
| Q1 2022 | $30,000 | -28.6% | 2,659 | 0.0% | 0.00% | -20.0% |
| Q4 2021 | $42,000 | -8.7% | 2,659 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $46,000 | -19.3% | 2,659 | 0.0% | 0.01% | -25.0% |
| Q2 2021 | $57,000 | +42.5% | 2,659 | 0.0% | 0.01% | +33.3% |
| Q1 2021 | $40,000 | +14.3% | 2,659 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $35,000 | +94.4% | 2,659 | +42.8% | 0.01% | +100.0% |
| Q3 2020 | $18,000 | +63.6% | 1,862 | +101.7% | 0.00% | +50.0% |
| Q2 2020 | $11,000 | +10.0% | 923 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $10,000 | – | 923 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 2,491,200 | $27,154,000 | 2.37% |
| Profit Investment Management, LLC | 281,890 | $3,071,000 | 2.26% |
| Sio Capital Management, LLC | 488,965 | $5,330,000 | 2.00% |
| Zebra Capital Management LLC | 14,766 | $161,000 | 0.47% |
| Prairiewood Capital, LLC | 50,165 | $547,000 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 256,696 | $2,798,000 | 0.42% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $1,700,000 | 0.29% |
| GLOBEFLEX CAPITAL L P | 100,843 | $1,099,000 | 0.27% |
| Epoch Investment Partners, Inc. | 2,757,646 | $30,059,000 | 0.18% |
| EMC Capital Management | 16,185 | $176,000 | 0.15% |